250 related articles for article (PubMed ID: 29600444)
1. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
Yan L; Deng Y; Zhou J; Zhao H; Wang G;
Infection; 2018 Jun; 46(3):385-393. PubMed ID: 29600444
[TBL] [Abstract][Full Text] [Related]
2. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
3. Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated Aminotransferases.
Deng YQ; Zhao H; Ma AL; Zhou JY; Xie SB; Zhang XQ; Zhang DZ; Xie Q; Zhang G; Shang J; Cheng J; Zhao WF; Zou ZQ; Zhang MX; Wang GQ;
Medicine (Baltimore); 2015 Nov; 94(45):e2003. PubMed ID: 26559292
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT.
Deng Y; Zhao H; Zhou J; Yan L; Wang G;
BMC Infect Dis; 2017 Sep; 17(1):650. PubMed ID: 28962551
[TBL] [Abstract][Full Text] [Related]
5. Complement 5a is an indicator of significant fibrosis and earlier cirrhosis in patients chronically infected with hepatitis B virus.
Deng Y; Zhao H; Zhou J; Yan L; Wang G;
Infection; 2017 Feb; 45(1):75-81. PubMed ID: 27605044
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
[TBL] [Abstract][Full Text] [Related]
7. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
Li Q; Lu C; Li W; Huang Y; Chen L
Clin Exp Med; 2018 Feb; 18(1):71-78. PubMed ID: 28884309
[TBL] [Abstract][Full Text] [Related]
8. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
Wang L; Li J; Yang K; Zhang H; Wang Q; Lv X; Guan S
Medicine (Baltimore); 2020 Jun; 99(23):e20548. PubMed ID: 32502018
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Tan YW; Zhou XB; Ye Y; He C; Ge GH
World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
[TBL] [Abstract][Full Text] [Related]
10. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
11. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).
Teshale E; Lu M; Rupp LB; Holmberg SD; Moorman AC; Spradling P; Vijayadeva V; Boscarino JA; Schmidt MA; Gordon SC;
J Viral Hepat; 2014 Dec; 21(12):917-20. PubMed ID: 25131445
[TBL] [Abstract][Full Text] [Related]
12. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
14. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
[TBL] [Abstract][Full Text] [Related]
15. Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT.
Wang H; Xue L; Yan R; Zhou Y; Wang MS; Cheng MJ; Huang HJ
J Viral Hepat; 2013 Apr; 20(4):e3-10. PubMed ID: 23490387
[TBL] [Abstract][Full Text] [Related]
16. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
[TBL] [Abstract][Full Text] [Related]
17. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
Zhou J; Deng Y; Yan L; Zhao H; Wang G;
Int J Infect Dis; 2016 Aug; 49():94-9. PubMed ID: 27292607
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
20. Association of coffee consumption and liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B: A 5-year population-based cohort study.
Chen CL; Chang WC; Yi CH; Hung JS; Liu TT; Lei WY; Hsu CS
J Formos Med Assoc; 2019 Feb; 118(2):628-635. PubMed ID: 30122312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
